Home Cart Sign in  
Chemical Structure| 773-76-2 Chemical Structure| 773-76-2

Structure of Chloroxine
CAS No.: 773-76-2

Chemical Structure| 773-76-2

*Storage: {[sel_prStorage]}

*Shipping: {[sel_prShipping]}

,{[proInfo.pro_purity]}

Chloroxine is a synthetic quinoline derivative with antibacterial activity, used in some shampoos for the treatment of dandruff and seborrheic dermatitis of the scalp.

4.5 *For Research Use Only !

{[proInfo.pro_purity]}
Cat. No.: {[proInfo.prAm]} Purity: {[proInfo.pro_purity]}

Change View

Size Price VIP Price

US Stock

Global Stock

In Stock
{[ item.pr_size ]} Inquiry {[ getRatePrice(item.pr_usd,item.pr_rate,item.mem_rate,item.pr_is_large_size_no_price, item.vip_usd) ]}

US Stock: ship in 0-1 business day
Global Stock: ship in 5-7 days

  • {[ item.pr_size ]}

In Stock

- +

Please Login or Create an Account to: See VIP prices and availability

US Stock: ship in 0-1 business day
Global Stock: ship in 2 weeks

  • 1-2 Day Shipping
  • High Quality
  • Technical Support
Product Citations

Alternative Products

Product Details of Chloroxine

CAS No. :773-76-2
Formula : C9H5Cl2NO
M.W : 214.05
SMILES Code : OC1=C2N=CC=CC2=C(Cl)C=C1Cl
MDL No. :MFCD00006786
InChI Key :WDFKMLRRRCGAKS-UHFFFAOYSA-N
Pubchem ID :2722

Safety of Chloroxine

GHS Pictogram:
Signal Word:Warning
Hazard Statements:H302-H315-H319-H335
Precautionary Statements:P261-P305+P351+P338

Isoform Comparison

Biological Activity

In Vitro:

Cell Line
Concentration Treated Time Description References
HEK293T cells 7.24 ±0.68 μM 24 hours To validate the inhibitory effect of Chloroxine on SARS-CoV-2 PLpro, results showed it could recover cellular ISGylation levels PMC8342870
Candida auris 0.39 µM to 0.94 µM 24 hours To evaluate the inhibitory effect of Chloroxine on Candida auris, results showed broad-spectrum inhibitory activity against multiple C. auris strains. PMC10470496
FHs 74 Int 0.5 µg/mL 72 hours Evaluate the cytotoxicity of chloroxine against normal intestinal cells, showing cytotoxicity to FHs 74 Int cells. PMC7558399
HT29 3.7 µg/mL 72 hours Evaluate the antiproliferative activity of chloroxine against intestinal cancer cells, showing cytotoxicity to HT29 cells. PMC7558399
Caco-2 1.3 µg/mL 72 hours Evaluate the antiproliferative activity of chloroxine against intestinal cancer cells, showing cytotoxicity to Caco-2 cells. PMC7558399
Yeast cells 10−3–10 µM 2.5 hours Evaluate the blocking effect of 8HQ-based blockers on HR H2 PMC10295836
Rat skinned skeletal muscle fibers 100 μM To evaluate the inhibitory effect of Chloroxine on RyR1 Ca2+ leak. Results showed that 100 μM Chloroxine significantly reduced RyR1 Ca2+ leak. PMC7000700
Human skinned skeletal muscle fibers 100 μM To evaluate the inhibitory effect of Chloroxine on RyR1 Ca2+ leak. Results showed that 100 μM Chloroxine significantly reduced RyR1 Ca2+ leak. PMC7000700
HEK293T cells 1 μM To validate the ability of Chloroxine to block HRH2 in mammalian cells, results showed a significant decrease in cAMP levels at 1 μM concentration. PMC9396701
CovCis 10 μM 7 days To evaluate the synergistic effect of chloroxine with cisplatin in platinum-resistant HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with cisplatin, significantly reducing cell survival. PMC8047034
Ov4Carbo 10 μM 7 days To evaluate the synergistic effect of chloroxine with carboplatin in platinum-resistant HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with carboplatin, significantly reducing cell survival. PMC8047034
OVCAR4 10 μM 7 days To evaluate the synergistic effect of chloroxine with carboplatin in platinum-sensitive HGSC cells. Results showed that chloroxine at 10 μM concentration synergized with carboplatin, significantly reducing cell survival. PMC8047034
HCT116 cells 10-50 µM 24 hours Measurement of H2S production and cell proliferation showed that chloroxine significantly reduced H2S production and inhibited cell proliferation PMC9223588
HepG2 cells 20 µM 24 hours Measurement of H2S production levels showed that chloroxine significantly reduced H2S production PMC9223588
HepG2 cells 15 µM 24 hours Measurement of intracellular amino acid levels showed that chloroxine significantly increased methionine levels and decreased cystathionine levels PMC9223588

In Vivo:

Species
Animal Model
Administration Dosage Frequency Description References
CD1 nu/nu mice HGSC intraperitoneal xenograft model Intraperitoneal injection 10 mg/kg Chloroxine once daily, carboplatin once weekly, for 4 weeks To evaluate the synergistic effect of chloroxine with carboplatin in platinum-resistant HGSC mouse model. Results showed that the combination of chloroxine and carboplatin maintained tumor volume at baseline for over 4 months. PMC8047034
Mice Mdx mouse model In vitro muscle incubation 0.01, 0.1, 1.0, 10, or 100 μM 10 eccentric contractions after 30 min incubation Chloroxine, as a small-molecule inhibitor of RyR1 calcium leak, partially attenuated eccentric contraction-induced force loss in mdx mouse muscle. PMC6995146

Protocol

Bio Calculators
Preparing Stock Solutions 1mg 5mg 10mg

1 mM

5 mM

10 mM

4.67mL

0.93mL

0.47mL

23.36mL

4.67mL

2.34mL

46.72mL

9.34mL

4.67mL

References

 

Historical Records

Categories